Seattle, WA , March 14, 2018 (GLOBE NEWSWIRE) — CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering India Globalization Capital Inc.’s (NYSE: American: IGC) partnership strategies that place the company in the forefront of cannabinoid-based Parkinson’s disease research.
India Globalization Capital is focused on developing cannabis-based therapeutics targeting a wide range of disease, including Parkinson’s disease. After partnering with a leading Parkinson’s disease institute, the company hopes to design clinical trials that could prove the efficacy of medical cannabis and help physicians prescribe the plant.
Parkinson’s disease affects about one million Americans and ten million individuals around the world, costing the economy more than $25 billion per year. While there is no cure for the disease, there are many different ways to manage symptoms. Medical marijuana has been one of